EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
Loading
Cash & Equivalents Over TimeStable
Percentile Rank86
3Y CAGR+2.1%
5Y CAGR+17.8%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+2.1%/yr
vs +25.3%/yr prior
5Y CAGR
+17.8%/yr
Recent deceleration
Acceleration
-23.2pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
2.3x
Strong expansion
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $101.82M | +2.1% |
| 2024 | $99.70M | -64.6% |
| 2023 | $281.26M | +194.1% |
| 2022 | $95.63M | -46.5% |
| 2021 | $178.59M | +297.7% |
| 2020 | $44.91M | +102.2% |
| 2019 | $22.21M | -42.7% |
| 2018 | $38.78M | +129.5% |
| 2017 | $16.90M | +10.4% |
| 2016 | $15.31M | - |